Investing.com - ObsEva reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
ObsEva announced earnings per share of $-0.130 on revenue of $10K. Analysts polled by Investing.com anticipated EPS of $-0.085 on revenue of $2.51M.
ObsEva shares are down 89% from the beginning of the year , still down 91.35% from its 52 week high of $2.45 set on Thursday, December 9, 2021.
ObsEva follows other major Healthcare sector earnings this month
ObsEva's report follows an earnings beat by AstraZeneca ADR on Thursday, November 10, 2022, who reported EPS of $1.67 on revenue of $10.98B, compared to forecasts EPS of $0.77 on revenue of $10.78B.
Amgen had beat expectations on Thursday, November 3, 2022 with third quarter EPS of $4.7 on revenue of $6.7B, compared to forecast for EPS of $4.44 on revenue of $6,561M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar